PPLPHARMA.NS
Piramal Pharma Limited
NSEINREQUITY
Healthcare
DELAYED
Last price
213.54
▼ 3.12 (1.44%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
217.25
Prev close
216.66
Day high
220.36
Day low
212.92
Volume
4.57M
Market cap
$282.63B
P/E (TTM)
—
52W range
132.30 – 220.36
Day trading desk
Gap from prior close
+0.27%
Prior close 216.66
VWAP
215.67
-0.99% from price
Relative volume
0.58×
Quiet session
Session range
3.39%
213.02 – 220.25
Position in range
7%
Near session low
ATR (14D)
7.78
3.64% of price
Prior day high
217.00
PDH
Prior day low
209.33
PDL
Bid / ask spread
—
Quote not published
Session volume
4.37M
Avg 7.48M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+3.40%
+4.8%
1M
+18.16%
+14.4%
3M
+19.46%
+16.4%
6M
+31.05%
+20.0%
YTD
+24.08%
+11.8%
1Y
+10.02%
-10.0%
3Y
+107.55%
+33.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PPLPHARMA.NS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
723.69M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 14, 26 | HDFC Trustee Co Ltd - HDFC Prudence Fund & HDFC Tax Saver fu Institution- Corporation |
— | 139.90K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
HDFC Trustee Co Ltd - HDFC Prudence Fund & HDFC Tax Saver fu |
Institution- Corporation | 93.39M | Sale |
Fundamentals
Market cap$282.63B
Enterprise value$327.14B
Revenue (TTM)$92.05B
Gross profit$54.69B
EBITDA$8.98B
Net income$-3.14B
EPS (TTM)$-2.35
Free cash flow—
Total cash$13.55B
Total debt$57.12B
Book value / share$61.50
Shares outstanding1.33B
Float610.63M
Short % of float—
Dividend yield0.08%
Beta (5Y)0.32
Valuation & profitability ratios
Trailing P/E—
Forward P/E52.37
PEG ratio—
Price / sales—
Price / book3.47
EV / revenue3.55
EV / EBITDA36.43
Gross margin59.41%
Operating margin-1.25%
Profit margin-3.41%
Return on equity—
Return on assets—
Debt / equity69.98
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $87.59B | $90.61B | $81.06B | $70.32B | -3.3% |
| Operating revenue | $87.59B | $90.61B | $81.06B | $70.32B | -3.3% |
| Cost of revenue | $35.84B | $35.72B | $32.59B | $30.00B | +0.3% |
| Gross profit | $51.75B | $54.89B | $48.48B | $40.32B | -5.7% |
| Research & development | $1.11B | $971.30M | $1.01B | $863.60M | +14.7% |
| Selling, general & admin | $6.52B | $6.05B | $5.67B | $5.55B | +7.6% |
| Total operating expense | $50.20B | $48.10B | $43.86B | $40.80B | +4.4% |
| Operating income | $1.55B | $6.79B | $4.62B | -$479.70M | -77.2% |
| Net interest income | -$3.34B | -$4.11B | -$4.37B | -$3.43B | +18.8% |
| Pre-tax income | -$1.76B | $4.15B | $1.79B | -$1.20B | -142.5% |
| Tax provision | $1.50B | $3.24B | $1.61B | $663.10M | -53.7% |
| Net income | -$3.26B | $911.30M | $178.20M | -$1.86B | -457.7% |
| Net income to common | -$3.26B | $911.30M | $178.20M | -$1.86B | -457.7% |
| Basic EPS | -2.46 | 0.69 | 0.14 | -1.54 | -456.5% |
| Diluted EPS | -2.46 | 0.69 | 0.14 | -1.54 | -456.5% |
| EBIT | $1.62B | $8.33B | $6.26B | $2.18B | -80.5% |
| EBITDA | $9.94B | $16.49B | $13.67B | $8.94B | -39.7% |
| Basic shares | 1.33B | 1.32B | 1.28B | 1.21B | +0.2% |
| Diluted shares | 1.33B | 1.33B | 1.28B | 1.21B | +0.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $12.00B | $3.69B | $3.57B | $1.96B | — | +225.2% |
| Cash & short-term investments | $13.35B | $3.92B | $5.04B | $6.60B | — | +240.6% |
| Accounts receivable | $21.58B | $23.50B | $21.34B | $17.99B | — | -8.2% |
| Inventory | $30.64B | $23.13B | $21.76B | $16.81B | — | +32.5% |
| Total current assets | $71.92B | $57.97B | $54.64B | $48.35B | — | +24.1% |
| Property, plant & equipment | $56.42B | $50.23B | $48.16B | $44.41B | — | +12.3% |
| Goodwill & intangibles | $41.42B | $40.87B | $42.90B | $44.46B | — | +1.3% |
| Total assets | $179.65B | $156.78B | $153.12B | $145.23B | — | +14.6% |
| Total current liabilities | $47.58B | $37.66B | $43.69B | $38.43B | — | +26.3% |
| Current debt | $11.96B | $15.06B | $20.75B | $21.21B | — | -20.6% |
| Long-term debt | $43.00B | $32.14B | $24.84B | $33.84B | — | +33.8% |
| Total debt | $56.75B | $48.56B | $47.10B | $56.37B | — | +16.8% |
| Total liabilities | $98.02B | $75.52B | $74.00B | $77.49B | — | +29.8% |
| Retained earnings | $6.92B | $10.49B | $9.71B | — | $8.62B | -34.1% |
| Shareholder equity | $81.63B | $81.25B | $79.11B | $67.73B | — | +0.5% |
| Working capital | $24.33B | $20.31B | $10.95B | $9.92B | — | +19.8% |
| Net tangible assets | $40.21B | $40.39B | $36.22B | $23.28B | — | -0.4% |
| Shares issued | 1.33B | 1.33B | 1.32B | 1.22B | — | +0.3% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$2.33B | $3.42B | $1.20B | -$1.61B | — | -168.3% |
| Depreciation & amortisation | $8.31B | $8.16B | $7.41B | $6.77B | — | +1.8% |
| Stock-based compensation | $417.20M | $480.00M | $274.70M | $0 | — | -13.1% |
| Change in working capital | $5.27B | -$4.88B | -$2.34B | -$3.02B | — | +208.0% |
| Operating cash flow | $16.53B | $8.92B | $10.05B | $4.84B | — | +85.2% |
| Capital expenditure | -$8.90B | -$6.64B | -$7.12B | -$9.65B | — | -34.0% |
| Investing cash flow | -$8.26B | -$4.77B | -$4.34B | -$13.39B | — | -73.0% |
| Dividends paid | -$185.50M | -$144.70M | — | -$670.00M | -$500.00M | -28.2% |
| Financing cash flow | -$389.80M | -$4.41B | -$4.22B | $8.18B | — | +91.2% |
| Free cash flow | $7.63B | $2.28B | $2.92B | -$4.81B | — | +234.6% |
| End cash position | $9.76B | $1.82B | $2.19B | $532.30M | — | +435.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $22.70B | $27.52B | $21.40B | $19.34B | $27.54B | -17.5% |
| Operating revenue | $22.70B | $27.52B | $21.40B | $19.34B | $27.54B | -17.5% |
| Cost of revenue | $8.52B | $10.56B | $7.86B | $6.94B | $9.55B | -19.3% |
| Gross profit | $14.18B | $16.96B | $13.54B | $12.40B | $17.99B | -16.4% |
| Total operating expense | $14.46B | $14.54B | $13.71B | $13.30B | $14.81B | -0.5% |
| Operating income | -$283.50M | $2.42B | -$170.10M | -$905.80M | $3.18B | -111.7% |
| Net interest income | -$880.80M | -$829.90M | -$892.40M | -$861.50M | -$1.04B | -6.1% |
| Pre-tax income | -$74.60M | $430.00M | -$938.60M | -$790.20M | $2.73B | -117.3% |
| Tax provision | $619.30M | $518.30M | $423.30M | $26.80M | $1.19B | +19.5% |
| Net income | -$693.90M | -$88.20M | -$1.36B | -$817.00M | $1.53B | -686.7% |
| Net income to common | -$693.90M | -$88.20M | -$1.36B | -$817.00M | $1.53B | -686.7% |
| Basic EPS | -0.52 | -0.07 | -1.03 | -0.62 | 1.16 | -642.9% |
| Diluted EPS | -0.52 | -0.07 | -1.03 | -0.62 | 1.16 | -642.9% |
| EBIT | $806.20M | $1.26B | -$46.20M | $71.30M | $3.76B | -36.0% |
| EBITDA | $3.04B | $3.44B | $2.08B | $2.04B | $6.19B | -11.7% |
| Basic shares | 1.33B | 1.26B | 1.32B | 1.32B | 1.32B | +5.9% |
| Diluted shares | 1.33B | 1.26B | 1.32B | 1.32B | 1.32B | +5.9% |
| Line item | 2026-03-31 | 2025-03-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $12.00B | $3.69B | +225.2% |
| Cash & short-term investments | $13.35B | $3.92B | +240.6% |
| Accounts receivable | $21.58B | $23.50B | -8.2% |
| Inventory | $30.64B | $23.13B | +32.5% |
| Total current assets | $71.92B | $57.97B | +24.1% |
| Property, plant & equipment | $56.42B | $50.23B | +12.3% |
| Goodwill & intangibles | $41.42B | $40.87B | +1.3% |
| Total assets | $179.65B | $156.78B | +14.6% |
| Total current liabilities | $47.58B | $37.66B | +26.3% |
| Current debt | $11.96B | $15.06B | -20.6% |
| Long-term debt | $43.00B | $32.14B | +33.8% |
| Total debt | $56.75B | $48.56B | +16.8% |
| Total liabilities | $98.02B | $75.52B | +29.8% |
| Retained earnings | $6.92B | $10.49B | -34.1% |
| Shareholder equity | $81.63B | $81.25B | +0.5% |
| Working capital | $24.33B | $20.31B | +19.8% |
| Net tangible assets | $40.21B | $40.39B | -0.4% |
| Shares issued | 1.33B | 1.33B | +0.3% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.66 | -0.52 | +21.2% |
| Mar 2026 | 0.75 | 1.33 | +77.1% |
| Dec 2025 | -0.08 | -0.72 | -858.8% |
| Sep 2025 | -0.29 | -0.75 | -158.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.01 | 1 | $23.21B | +13.6% |
| Next quarter | 0.21 | 1 | $24.78B | +15.8% |
| Current year | 1.43 | 10 | $102.36B | +15.4% |
| Next year | 4.07 | 10 | $117.20B | +14.5% |
Analyst targets & ownership
Mean target$233.27
High target$265.00
Low target$200.00
Implied upside9.24%
Analyst count11
ConsensusNONE
Strong buy / Buy2 / 8
Hold0
Sell / Strong sell0 / 1
Held by insiders54.53%
Held by institutions20.91%
Institutions holding61
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
211.26
+1.08% from price
SMA 20
205.62
+3.91% from price
SMA 50
185.06
+15.46% from price
SMA 100
174.59
+22.31% from price
SMA 200
170.77
+25.12% from price
EMA 12
209.00
+2.17% from price
EMA 26
200.87
+6.31% from price
EMA 50
190.85
+11.89% from price
RSI (14)
65.3
Neutral
MACD (12,26,9)
8.13
Hist -0.38
ATR (14)
7.78
3.64% of price
Realised vol 30D
32.1%
Annualised
Bollinger upper
220.60
20, 2σ
Bollinger lower
190.64
20, 2σ
50 / 200 cross
Golden
185.06 vs 170.77
Trend bias
Above 200
+25.12%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.10
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
32.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-36.0%
Peak to trough
Max drawdown 5Y
-66.3%
Peak to trough
ATR 14
7.78
3.64% of price
Beta (reported)
0.32
5Y monthly, from filing
Dividends & splits
Forward rate$0.14 / yr
Forward yield0.08%
5-year avg yield—
Payout ratio15.07%
Ex-dividend dateJul 16, 2025
Next pay date—
Last split—
Split date—
Headlines
10-man Atletico snatch Villarreal draw as Alvarez returns
AFP · 12m ago
Should You Buy Oracle Stock Before September? The Answer Might Surprise You.
Motley Fool · 14m ago
Fed’s Kashkari says rising Treasury yields not a concern
Investing.com · 17m ago
Bill Ackman's Pershing Square invests $1.1B in fintech giant
TheStreet · 17m ago
Rachel Cruze and George Kamel share the spending 'clues' that reveal if you're broke, average or wealthy
Moneywise · 24m ago
An e.l.f. Beauty Insider Sells 5,718 Shares. Here's What That Means for Investors.
Motley Fool · 27m ago
Dow Jones Futures Due; Nvidia Earnings, Canada Tariffs, Warsh In Focus
Investor's Business Daily · 28m ago
Your Last Chance to Buy Nvidia Stock for Cheap in 2026 May Be Near
Motley Fool · 29m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.